Your browser doesn't support javascript.
loading
Whole-genome landscapes of major melanoma subtypes.
Hayward, Nicholas K; Wilmott, James S; Waddell, Nicola; Johansson, Peter A; Field, Matthew A; Nones, Katia; Patch, Ann-Marie; Kakavand, Hojabr; Alexandrov, Ludmil B; Burke, Hazel; Jakrot, Valerie; Kazakoff, Stephen; Holmes, Oliver; Leonard, Conrad; Sabarinathan, Radhakrishnan; Mularoni, Loris; Wood, Scott; Xu, Qinying; Waddell, Nick; Tembe, Varsha; Pupo, Gulietta M; De Paoli-Iseppi, Ricardo; Vilain, Ricardo E; Shang, Ping; Lau, Loretta M S; Dagg, Rebecca A; Schramm, Sarah-Jane; Pritchard, Antonia; Dutton-Regester, Ken; Newell, Felicity; Fitzgerald, Anna; Shang, Catherine A; Grimmond, Sean M; Pickett, Hilda A; Yang, Jean Y; Stretch, Jonathan R; Behren, Andreas; Kefford, Richard F; Hersey, Peter; Long, Georgina V; Cebon, Jonathan; Shackleton, Mark; Spillane, Andrew J; Saw, Robyn P M; López-Bigas, Núria; Pearson, John V; Thompson, John F; Scolyer, Richard A; Mann, Graham J.
Afiliação
  • Hayward NK; Melanoma Institute Australia, The University of Sydney, North Sydney, Sydney, New South Wales 2065, Australia.
  • Wilmott JS; QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.
  • Waddell N; Melanoma Institute Australia, The University of Sydney, North Sydney, Sydney, New South Wales 2065, Australia.
  • Johansson PA; Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia.
  • Field MA; QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.
  • Nones K; Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia.
  • Patch AM; QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.
  • Kakavand H; Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland 4878, Australia.
  • Alexandrov LB; QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.
  • Burke H; Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia.
  • Jakrot V; QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.
  • Kazakoff S; Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia.
  • Holmes O; Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia.
  • Leonard C; Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA.
  • Sabarinathan R; Melanoma Institute Australia, The University of Sydney, North Sydney, Sydney, New South Wales 2065, Australia.
  • Mularoni L; Melanoma Institute Australia, The University of Sydney, North Sydney, Sydney, New South Wales 2065, Australia.
  • Wood S; QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.
  • Xu Q; Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia.
  • Waddell N; QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.
  • Tembe V; Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia.
  • Pupo GM; QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.
  • De Paoli-Iseppi R; Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia.
  • Vilain RE; Research Program on Biomedical Informatics, IMIM Hospital del Mar Medical Research Institute, Universitat Pompeu Fabra, 08003 Barcelona, Catalonia, Spain.
  • Shang P; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain.
  • Lau LMS; Research Program on Biomedical Informatics, IMIM Hospital del Mar Medical Research Institute, Universitat Pompeu Fabra, 08003 Barcelona, Catalonia, Spain.
  • Dagg RA; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain.
  • Schramm SJ; QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.
  • Pritchard A; Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia.
  • Dutton-Regester K; QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.
  • Newell F; Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia.
  • Fitzgerald A; Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia.
  • Shang CA; Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, Sydney, New South Wales 2145, Australia.
  • Grimmond SM; Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, Sydney, New South Wales 2145, Australia.
  • Pickett HA; Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia.
  • Yang JY; Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia.
  • Stretch JR; Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia.
  • Behren A; Children's Medical Research Institute, The University of Sydney, Westmead, Sydney, New South Wales 2145, Australia.
  • Kefford RF; Children's Hospital at Westmead, The University of Sydney, Westmead, New South Wales Sydney, 2145, Australia.
  • Hersey P; Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, Sydney, New South Wales 2145, Australia.
  • Long GV; QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.
  • Cebon J; QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.
  • Shackleton M; QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.
  • Spillane AJ; Bioplatforms Australia, North Ryde, Sydney, New South Wales 2109, Australia.
  • Saw RPM; Bioplatforms Australia, North Ryde, Sydney, New South Wales 2109, Australia.
  • López-Bigas N; University of Melbourne Centre for Cancer Research, University of Melbourne, Parkville, Melbourne, Victoria 3052, Australia.
  • Pearson JV; Children's Medical Research Institute, The University of Sydney, Westmead, Sydney, New South Wales 2145, Australia.
  • Thompson JF; School of Mathematics and Statistics, The University of Sydney, Sydney, New South Wales 2006, Australia.
  • Scolyer RA; Melanoma Institute Australia, The University of Sydney, North Sydney, Sydney, New South Wales 2065, Australia.
  • Mann GJ; Olivia Newton-John Cancer Research Institute, La Trobe University, Austin Health, Heidelberg, Melbourne, Victoria 3084, Australia.
Nature ; 545(7653): 175-180, 2017 05 11.
Article em En | MEDLINE | ID: mdl-28467829
ABSTRACT
Melanoma of the skin is a common cancer only in Europeans, whereas it arises in internal body surfaces (mucosal sites) and on the hands and feet (acral sites) in people throughout the world. Here we report analysis of whole-genome sequences from cutaneous, acral and mucosal subtypes of melanoma. The heavily mutated landscape of coding and non-coding mutations in cutaneous melanoma resolved novel signatures of mutagenesis attributable to ultraviolet radiation. However, acral and mucosal melanomas were dominated by structural changes and mutation signatures of unknown aetiology, not previously identified in melanoma. The number of genes affected by recurrent mutations disrupting non-coding sequences was similar to that affected by recurrent mutations to coding sequences. Significantly mutated genes included BRAF, CDKN2A, NRAS and TP53 in cutaneous melanoma, BRAF, NRAS and NF1 in acral melanoma and SF3B1 in mucosal melanoma. Mutations affecting the TERT promoter were the most frequent of all; however, neither they nor ATRX mutations, which correlate with alternative telomere lengthening, were associated with greater telomere length. Most melanomas had potentially actionable mutations, most in components of the mitogen-activated protein kinase and phosphoinositol kinase pathways. The whole-genome mutation landscape of melanoma reveals diverse carcinogenic processes across its subtypes, some unrelated to sun exposure, and extends potential involvement of the non-coding genome in its pathogenesis.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Genoma Humano / Melanoma / Mutação Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Nature Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Genoma Humano / Melanoma / Mutação Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Nature Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Austrália